Glenmark Pharmaceuticals Limited — Updates, 27-02-2026: Press Release
27-02-2026 | 09:19 am
27-02-2026 | 09:19 am
Glenmark Pharma's US unit is launching Sodium Phosphates Injection USP vials. Distribution starts April 2026. The product targets a $66.8 million annual market, expanding Glenmark's institutional portfolio.
No comments yet. Be the first to comment!
